Semler Scientific, Inc.
SMLR
$33.60
$0.802.44%
| Weiss Ratings | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B | |||
| Rating Factors | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.36 | |||
| Price History | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.60% | |||
| 30-Day Total Return | -35.76% | |||
| 60-Day Total Return | -47.93% | |||
| 90-Day Total Return | 9.02% | |||
| Year to Date Total Return | -38.46% | |||
| 1-Year Total Return | 4.97% | |||
| 2-Year Total Return | 67.83% | |||
| 3-Year Total Return | -22.76% | |||
| 5-Year Total Return | -16.93% | |||
| 52-Week High % Change | -59.78% | |||
| 52-Week Low % Change | 57.09% | |||
| Price | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $81.56 | |||
| 52-Week Low Price | $20.88 | |||
| 52-Week Low Price (Date) | May 08, 2024 | |||
| 52-Week High Price (Date) | Dec 17, 2024 | |||
| Valuation | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 314.76M | |||
| Enterprise Value | 299.92M | |||
| Price/Earnings (TTM) | 6.67 | |||
| Earnings Per Share (TTM) | 4.92 | |||
| Earnings Per Share Growth | 87.09% | |||
| Price/Earnings To Growth | 0.08 | |||
| Price/Sales (TTM) | 4.99 | |||
| Price/Book (Q) | 1.36 | |||
| Enterprise Value/Revenue (TTM) | 5.33 | |||
| Price | $33.60 | |||
| Enterprise Value/EBITDA (TTM) | 14.14 | |||
| Enterprise Value/EBIT | 14.33 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 8.57M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 774 4211 | |||
| Address | 2340-2348 Walsh Avenue Santa Clara, CA 95051 | |||
| Website | www.semlerscientific.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 37.18% | |||
| Profit Margin | 72.65% | |||
| Management Effectiveness | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.23% | |||
| Return on Equity | 27.04% | |||
| Income Statement | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 56.29M | |||
| Total Revenue (TTM) | 56.29M | |||
| Revenue Per Share | $6.57 | |||
| Gross Profit (TTM) | 51.53M | |||
| EBITDA (TTM) | 21.22M | |||
| EBIT (TTM) | 20.93M | |||
| Net Income (TTM) | 40.90M | |||
| Net Income Avl. to Common (TTM) | 40.90M | |||
| Total Revenue Growth (Q YOY) | -17.56% | |||
| Earnings Growth (Q YOY) | 591.92% | |||
| EPS Diluted (TTM) | 4.92 | |||
| EPS Diluted Growth (Q YOY) | 534.57% | |||
| Balance Sheet | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.92M | |||
| Cash Per Share (Q) | $1.74 | |||
| Total Current Assets (Q) | 22.69M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 230.75M | |||
| Current Ratio (Q) | 3.594 | |||
| Book Value Per Share (Q) | $24.15 | |||
| Total Assets (Q) | 239.83M | |||
| Total Current Liabilities (Q) | 6.31M | |||
| Total Debt (Q) | 70.00K | |||
| Total Liabilities (Q) | 9.08M | |||
| Total Common Equity (Q) | 230.75M | |||
| Cash Flow | SMLR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -189.98M | |||
| Cash from Financing (TTM) | 117.19M | |||
| Net Change in Cash (TTM) | -48.38M | |||
| Levered Free Cash Flow (TTM) | 15.59M | |||
| Cash from Operations (TTM) | 24.41M | |||
